Who we are
“Innofamily since 70’s”
The Paolo Gobbi Frattini company
Paolo Gobbi Frattini Srl was founded in the 1970s based on the family business where Renzo Gobbi Frattini (father), a pioneer in the automated production of flexible bags and infusion sets, was the creator of major technological innovations with important patents for products and production processes that are still very relevant today.
Over the years, Paolo Gobbi Frattini through the company bearing the same name, has founded several other companies as the only partner, including Haemopharm, maintaining the innovative tradition in the biomedical sector with innovative in-house manufactured process machines and multiple product patents in drug management through biomedical bags and their accessories.
The production
The Paolo Gobbi Frattini Group produces flexible bags for sterile solutions in PVC and PVC-FREE, drug reconstitution and delivery systems, and components for advanced therapeutic applications. The raw materials used are selected with the highest professionalism with strict criteria of biocompatibility with molecules and adequate oxygen and vapor barrier. The company is distinguished by its level of specialization, an ongoing commitment to research and development of innovative solutions, with a focus on the design of advanced systems and components for drug reconstitution and delivery, many of which are patented. Paolo Gobbi Frattini Srl Group‘s advanced bag systems and their accessories are developed and produced entirely in-house, in the Lombardy plant in Tovo S. Agatha (SO) – Italy, in compliance with the strictest and highest quality standards.
Proprietary technology of production lines
An important competitive advantage is the exclusive and proprietary technology of its production lines, which has been a flagship of the company since its inception. Modular business management ensures maximum efficiency through versatile, advanced processes, high product reliability and consistent performance levels over time.
Direct involvement of ownership in the conduct of the business
Paolo Gobbi Frattini owns 100 % of the share capital of all group companies and is personally present and operational as CEO of the companies, guaranteeing a long-term perspective. This is a key aspect of corporate identity, facilitating communication, accelerating decision-making processes, to better meet the needs of Clients.
Strategic Guidelines
Our mission & vision
The mission of the Paolo Gobbi Frattini Group is to consolidate its leadership in process technology and product technology as a “partner of choice” for large companies globally. The international expansion strategy is part of a broader logic of growth, based on a dynamic and modern organization, able to compete globally, and to arrive first in very specialized market areas, with high quality products and services.
A dynamic entrepreneurial spirit, oriented towards a constant quest for excellence for over 40 years of history, places four fundamental strategic assets at the center of the Company’s strategy, which represent the pillars of the Vision of Paolo Gobbi Frattini Group Srl: TOTAL QUALITY, INNOVATION, DIVERSIFICATION, PARTNERSHIP.
A global business network
The ability to preside over the global market is a crucially important aspect of company policy. In fact, customers are increasingly sensitive to establishing collaborations with industry players who, in addition to offering products of excellence, are also able to guarantee a widespread presence in different areas of the world, thanks to the support of strategic partnerships.
Pursuing these goals, the Paolo Gobbi Frattini Group has over the years developed commercial agreements in Europe, North and South America, Australia, the Middle East and the Far East, thanks to which it is able to actively preside over the geographical areas of greatest interest to its business.
The group
Haemopharm is a company that is part of the Paolo Gobbi Frattini Group. Its mission is marketing, digital marketing and IP for all activities of the Paolo Gobbi Frattini Group.
Quatalia Science is mainly in charge of the pharmaceutical division of the group including the drug regulatory part.
LUscientific is a business platform that also includes the marketing of pharmaceutical raw materials.
Both Quatalia and LUscientific are based in Belgrade, Serbia, enabling local business consolidation and facilitating penetration into emerging markets.
A network of partnerships and business relationships, on a national and international scale, allows the Paolo Gobbi Frattini Group to extend its core business and diversify its offering through collaboration with important players in the sector.
In May 2005, Haemopharm signed a cooperation agreement with SIAD Healthcare (now Medigas Italia) for the development, production and marketing of a new line of stem cell and tissue cryopreservation systems: SAFE2
The agreement with Medigas Italia expands Haemopharm’s presence in a new market segment and allows it to be joined by a trusted Partner to continue the search for increasingly innovative solutions for cell therapies. The goal for both companies is to offer a product line that fully meets the rigorous needs of cryopreservation banks.
The ongoing collaboration with Medigas Italia materialized in 2015 in a contractual joint venture: ADVATIS, “Advanced Therapies Innovative Solutions,” was born, providing innovative solutions in the field of cryopreservation and cell therapies and offering a wide range of products to cover the different stages of stem cell and tissue collection, handling and storage. With a high level of flexibility and with the support of the R&D team, ADVATIS can offer tailor-made solutions to meet any customer need.
St. AGATHA: From industrial research, to therapy
It is a unique medical centre located within the Paolo Gobbi Frattini Srl industry. This clinical division combines the medical-scientific world with the industrial production of advanced therapeutic systems.
Corporate Responsibility
The success of the Paolo Gobbi Frattini Group is based on a solid network of values, to which the Company’s team renews its commitment daily.
Responsibility, ethics in work, reliability, respect for the individual, transparency in the management of the Company, fairness in the management of human resources, fairness and clarity in contracts, loyalty to commitments made, observance of laws, respect for institutions in every country in the world: these are the fundamental principles of reference, which are combined with a culture oriented towards the Client, with whom the Paolo Gobbi Frattini Group aims to establish solid and lasting partnerships.
The responsibility of the Paolo Gobbi Frattini Group is also expressed towards the environment, with the search for technical solutions that allow a better use of resources and greater environmental sustainability, waste materials are supplied to companies specializing in recycling while most of the energy is produced through its own photovoltaic plant.